🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This was a prospective, multicenter, open label extension (OLE) trial on th...
Status
Terminated
Location
Investigator site 115 - US0010086
Start Date
2021-07-15
Trial ID
NCT04598477
Treatments Being Tested
This study aims to evaluate the efficacy, safety and tolerability, pharmaco...
Status
Terminated
Location
Thrive Health - Beverly Hills
Start Date
2024-03-27
Trial ID
NCT06307613
Treatments Being Tested
This study is part of the ADAPT Forward platform study (NCT07294170). ADAPT...
Status
Recruiting
Location
Visionary Investigators Network
Start Date
2026-07-10
Trial ID
NCT07673627
Treatments Being Tested
This is a prospective, multicenter, randomized, double-blinded, placebo-con...
Status
Completed
Location
Investigator site 77 - US0010086
Start Date
2020-12-01
Trial ID
NCT04598451
Treatments Being Tested
The purpose of this study is to evaluate the safety of efgartigimod PH20 SC...
Status
Terminated
Location
Medical Dermatology Specialists
Start Date
2023-03-22
Trial ID
NCT05681481
Treatments Being Tested
This study's purpose is to measure the treatment response from efgartigimod...
Status
Completed
Location
Neuromuscular Research Center
Start Date
2022-10-12
Trial ID
NCT05523167
Treatments Being Tested
The main purpose of this study is to measure how well adults with new-onset...
Status
Recruiting
Location
University of California, San Diego - Altman Clinical and Translational Research Institute (ACTRI)
Start Date
2025-04-17
Trial ID
NCT06909214
Treatments Being Tested
The main purpose of this study is to evaluate the effect and safety of efga...
Status
Recruiting
Location
Arizona Arthritis and Rheumatology Associates
Start Date
2024-11-11
Trial ID
NCT06655155
Treatments Being Tested
ARGX-113-2009 is an operationally seamless 2-part, phase 2/3, prospective, ...
Status
Completed
Location
Investigator site 74 - US0010178
Start Date
2022-06-09
Trial ID
NCT05267600
Treatments Being Tested
The purpose of this study is to evaluate the long-term safety and tolerabil...
Status
Completed
Location
Investigator site 6 - US0010032
Start Date
2021-04-26
Trial ID
NCT04818671
Treatments Being Tested